ATE305037T1 - Peptide, die fähig sind die sh3-domäne des gap- proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung - Google Patents
Peptide, die fähig sind die sh3-domäne des gap- proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendungInfo
- Publication number
- ATE305037T1 ATE305037T1 AT95941126T AT95941126T ATE305037T1 AT E305037 T1 ATE305037 T1 AT E305037T1 AT 95941126 T AT95941126 T AT 95941126T AT 95941126 T AT95941126 T AT 95941126T AT E305037 T1 ATE305037 T1 AT E305037T1
- Authority
- AT
- Austria
- Prior art keywords
- domain
- pct
- binding
- preparation
- coding dna
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- C07K14/4706—Guanosine triphosphatase activating protein, GAP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9413955A FR2727116B1 (fr) | 1994-11-22 | 1994-11-22 | Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation |
FR9505753A FR2734266B1 (fr) | 1995-05-16 | 1995-05-16 | Peptides capables de se lier au domaine sh3 de la proteine gap sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation |
PCT/FR1995/001539 WO1996016169A1 (fr) | 1994-11-22 | 1995-11-22 | Peptides capables de se lier au domaine sh3 de la proteine gap, sequences nucleotidiques codant pour ces peptides, leur preparation et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE305037T1 true ATE305037T1 (de) | 2005-10-15 |
Family
ID=26231549
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95941126T ATE305037T1 (de) | 1994-11-22 | 1995-11-22 | Peptide, die fähig sind die sh3-domäne des gap- proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung |
Country Status (18)
Country | Link |
---|---|
US (1) | US5886150A (de) |
EP (1) | EP0793721B1 (de) |
JP (2) | JPH10509044A (de) |
AT (1) | ATE305037T1 (de) |
AU (1) | AU713937B2 (de) |
BR (1) | BR9510067A (de) |
CA (1) | CA2204438A1 (de) |
CZ (1) | CZ292538B6 (de) |
DE (1) | DE69534471T2 (de) |
DK (1) | DK0793721T3 (de) |
ES (1) | ES2248800T3 (de) |
FI (1) | FI972170A0 (de) |
HU (1) | HU221410B1 (de) |
IL (1) | IL116026A (de) |
MX (1) | MX9703364A (de) |
NO (1) | NO972313L (de) |
SK (1) | SK287034B6 (de) |
WO (1) | WO1996016169A1 (de) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2780062B1 (fr) * | 1998-06-17 | 2000-07-28 | Rhone Poulenc Rorer Sa | Anticorps monoclonaux diriges contre la proteine g3bp, et leurs utilisations |
MY126795A (en) * | 1998-10-23 | 2006-10-31 | Amgen K A Inc | Dimeric thrombopoietic peptide mimetics binding to mp1 receptor and having thrombopoietic activity. |
US6864355B1 (en) | 2000-05-02 | 2005-03-08 | Yale University | Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
US20040022779A1 (en) * | 2000-06-16 | 2004-02-05 | Thomas Rudel | Method for identifying apoptosis-modified proteins |
EP1377828A4 (de) * | 2001-04-10 | 2006-11-15 | Childrens Medical Center | Verfahren zur analyse und markierung von protein-protein-wechselwirkungen |
US20050069999A1 (en) * | 2001-07-09 | 2005-03-31 | Sharma Sreenath V | Sh3 domain binding inhibitors |
JPWO2003006060A1 (ja) * | 2001-07-09 | 2004-10-28 | 協和醗酵工業株式会社 | Sh3ドメイン結合阻害剤 |
AUPR721101A0 (en) * | 2001-08-23 | 2001-09-13 | University Of Queensland, The | Nucleic acid and polypeptide linked to breast cancer |
MX2007000216A (es) * | 2004-07-08 | 2007-03-15 | Amgen Inc | Peptidos terapeuticos. |
EA011879B1 (ru) * | 2004-09-24 | 2009-06-30 | Эмджин Инк. | МОЛЕКУЛЫ С МОДИФИЦИРОВАННЫМ Fc ФРАГМЕНТОМ |
US8008453B2 (en) | 2005-08-12 | 2011-08-30 | Amgen Inc. | Modified Fc molecules |
JO3324B1 (ar) | 2006-04-21 | 2019-03-13 | Amgen Inc | مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية |
US11237168B2 (en) * | 2019-06-26 | 2022-02-01 | St. Jude Children's Research Hospital | Method for identifying modulators of G3BP activity |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA894726B (en) * | 1988-06-27 | 1990-03-28 | Akzo Nv | Coccidiosis vaccine |
AU652724B2 (en) * | 1989-08-21 | 1994-09-08 | Chiron Corporation | Peptides from GTPase-activating protein (GAP) and diagnostic and therapeutic use thereof |
EP0496162A3 (en) * | 1990-12-24 | 1993-09-01 | Merck & Co. Inc. | Peptide inhibitors of ras-gap interaction |
FR2694296B1 (fr) * | 1992-07-30 | 1994-09-02 | Rhone Poulenc Rorer Sa | Peptides inhibant l'activité des protéines ras, préparation et utilisation. |
AU6083894A (en) * | 1993-01-15 | 1994-08-15 | Schering Corporation | Ras associated gap proteins |
-
1995
- 1995-11-16 IL IL11602695A patent/IL116026A/xx not_active IP Right Cessation
- 1995-11-22 US US08/836,791 patent/US5886150A/en not_active Expired - Fee Related
- 1995-11-22 ES ES95941126T patent/ES2248800T3/es not_active Expired - Lifetime
- 1995-11-22 MX MX9703364A patent/MX9703364A/es not_active IP Right Cessation
- 1995-11-22 AU AU42636/96A patent/AU713937B2/en not_active Ceased
- 1995-11-22 DK DK95941126T patent/DK0793721T3/da active
- 1995-11-22 BR BR9510067A patent/BR9510067A/pt not_active Application Discontinuation
- 1995-11-22 AT AT95941126T patent/ATE305037T1/de not_active IP Right Cessation
- 1995-11-22 SK SK629-97A patent/SK287034B6/sk not_active IP Right Cessation
- 1995-11-22 HU HU9702079A patent/HU221410B1/hu not_active IP Right Cessation
- 1995-11-22 WO PCT/FR1995/001539 patent/WO1996016169A1/fr active IP Right Grant
- 1995-11-22 CZ CZ19971545A patent/CZ292538B6/cs not_active IP Right Cessation
- 1995-11-22 JP JP8516632A patent/JPH10509044A/ja not_active Ceased
- 1995-11-22 CA CA002204438A patent/CA2204438A1/fr not_active Abandoned
- 1995-11-22 EP EP95941126A patent/EP0793721B1/de not_active Expired - Lifetime
- 1995-11-22 DE DE69534471T patent/DE69534471T2/de not_active Expired - Lifetime
-
1997
- 1997-05-21 FI FI972170A patent/FI972170A0/fi not_active Application Discontinuation
- 1997-05-21 NO NO972313A patent/NO972313L/no not_active Application Discontinuation
-
2005
- 2005-10-25 JP JP2005309422A patent/JP2006122049A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
SK62997A3 (en) | 1998-02-04 |
AU4263696A (en) | 1996-06-17 |
BR9510067A (pt) | 1997-12-30 |
CA2204438A1 (fr) | 1996-05-30 |
JP2006122049A (ja) | 2006-05-18 |
NO972313D0 (no) | 1997-05-21 |
CZ154597A3 (en) | 1997-10-15 |
MX9703364A (es) | 1997-08-30 |
FI972170A (fi) | 1997-05-21 |
WO1996016169A1 (fr) | 1996-05-30 |
IL116026A (en) | 2005-08-31 |
HUT77029A (hu) | 1998-03-02 |
FI972170A0 (fi) | 1997-05-21 |
CZ292538B6 (cs) | 2003-10-15 |
AU713937B2 (en) | 1999-12-16 |
DK0793721T3 (da) | 2006-01-30 |
DE69534471T2 (de) | 2006-06-22 |
EP0793721B1 (de) | 2005-09-21 |
SK287034B6 (sk) | 2009-10-07 |
DE69534471D1 (de) | 2006-02-02 |
IL116026A0 (en) | 1996-01-31 |
US5886150A (en) | 1999-03-23 |
HU221410B1 (en) | 2002-09-28 |
NO972313L (no) | 1997-05-21 |
JPH10509044A (ja) | 1998-09-08 |
ES2248800T3 (es) | 2006-03-16 |
EP0793721A1 (de) | 1997-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200001709T2 (tr) | Yeni neisseria meningitids yüzey proteini | |
EP0590071A4 (en) | Substantially pure receptor like tgf--g(b)1 binding molecules and uses thereof | |
ATE305037T1 (de) | Peptide, die fähig sind die sh3-domäne des gap- proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung | |
FI962247A (fi) | Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät | |
DK1025236T3 (da) | Human checkpoint kinase, HCDS1, præparater og fremgangsmåde | |
EP1071443A4 (de) | Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen | |
EP1005539A4 (de) | Ikk-alpha proteine, nukleinsäuren und verfahren | |
BG103872A (en) | Glycoconjugates of 20(s)-camptotecin | |
BR9710919A (pt) | Proteina purificada sr-p70 | |
AU2174392A (en) | Adn sequences of the human papillomavirus type 42, and diagnostic application thereof | |
BR9910787A (pt) | Métodos e composições úteis para modulação deangiogênese usando tirosina cinase src | |
DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
CA2287902A1 (en) | Isolated nucleic acid molecules encoding ssx family members and uses thereof | |
DE69529235D1 (de) | Menschliche dnase i varianten | |
SE9604439D0 (sv) | New receptor | |
DE69812597D1 (de) | Peptide zur Inhibition von HPV E7 Proteinen | |
GB2329896A (en) | Enzyme and DNA sequence encoding same | |
WO2002070560A3 (en) | Nuclear hormone receptor ligand binding domain | |
ID27964A (id) | Turuna-azabisikloheptana n-tersubstitusi, pembuatan dan penggunaannya |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0793721 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |